Together, these results underscore the critical role of preclinical models in identifying mechanistic elements (i.e., RBC TLR9) that may drive differential host inflammatory responses and identify RBC TLR9–mediated DNA regulation as a potentially treatable trait in sepsis. The gene discussed is TLR9; the disease is Sepsis.